- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/095 - OxytocinsVasopressinsRelated peptides
Patent holdings for IPC class A61K 38/095
Total number of patents in this class: 234
10-year publication summary
|
4
|
6
|
13
|
27
|
41
|
31
|
39
|
31
|
36
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 705 |
17 |
| Mallinckrodt Pharmaceuticals Ireland Ltd | 163 |
14 |
| ACADIA Pharmaceuticals Inc. | 210 |
8 |
| BIOVIE, Inc. | 32 |
7 |
| Amryt Endo, Inc. | 50 |
6 |
| Levo Therapeutics, Inc. | 25 |
5 |
| Acerus Pharmaceuticals USA, LLC | 13 |
5 |
| Arecor Limited | 103 |
4 |
| Monash University | 710 |
4 |
| Sunnybrook Research Institute | 238 |
4 |
| XOMA (US) LLC | 71 |
4 |
| OptiNose, Inc. | 89 |
4 |
| Maskbegone LLC | 4 |
4 |
| PH Health Limited | 113 |
4 |
| Novartis AG | 10730 |
3 |
| The Trustees of Columbia University in the City of New York | 3584 |
3 |
| Baylor College of Medicine | 961 |
3 |
| MannKind Corporation | 517 |
3 |
| Tulex Pharmaceuticals Inc., DBA Tulex Pharmaceuticals Inc. | 20 |
3 |
| Elgan Pharma Ltd | 14 |
3 |
| Other owners | 126 |